Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 22;24(6):5980.
doi: 10.3390/ijms24065980.

Ruthenium Complexes with Protic Ligands: Influence of the Position of OH Groups and π Expansion on Luminescence and Photocytotoxicity

Affiliations

Ruthenium Complexes with Protic Ligands: Influence of the Position of OH Groups and π Expansion on Luminescence and Photocytotoxicity

Olaitan E Oladipupo et al. Int J Mol Sci. .

Abstract

Protic ruthenium complexes using the dihydroxybipyridine (dhbp) ligand combined with a spectator ligand (N,N = bpy, phen, dop, Bphen) have been studied for their potential activity vs. cancer cells and their photophysical luminescent properties. These complexes vary in the extent of π expansion and the use of proximal (6,6'-dhbp) or distal (4,4'-dhbp) hydroxy groups. Eight complexes are studied herein as the acidic (OH bearing) form, [(N,N)2Ru(n,n'-dhbp)]Cl2, or as the doubly deprotonated (O- bearing) form. Thus, the presence of these two protonation states gives 16 complexes that have been isolated and studied. Complex 7A, [(dop)2Ru(4,4'-dhbp)]Cl2, has been recently synthesized and characterized spectroscopically and by X-ray crystallography. The deprotonated forms of three complexes are also reported herein for the first time. The other complexes studied have been synthesized previously. Three complexes are light-activated and exhibit photocytotoxicity. The log(Do/w) values of the complexes are used herein to correlate photocytotoxicity with improved cellular uptake. For Ru complexes 1-4 bearing the 6,6'-dhbp ligand, photoluminescence studies (all in deaerated acetonitrile) have revealed that steric strain leads to photodissociation which tends to reduce photoluminescent lifetimes and quantum yields in both protonation states. For Ru complexes 5-8 bearing the 4,4'-dhbp ligand, the deprotonated Ru complexes (5B-8B) have low photoluminescent lifetimes and quantum yields due to quenching that is proposed to involve the 3LLCT excited state and charge transfer from the [O2-bpy]2- ligand to the N,N spectator ligand. The protonated OH bearing 4,4'-dhbp Ru complexes (5A-8A) have long luminescence lifetimes which increase with increasing π expansion on the N,N spectator ligand. The Bphen complex, 8A, has the longest lifetime of the series at 3.45 μs and a photoluminescence quantum yield of 18.7%. This Ru complex also exhibits the best photocytotoxicity of the series. A long luminescence lifetime is correlated with greater singlet oxygen quantum yields because the triplet excited state is presumably long-lived enough to interact with 3O2 to yield 1O2.

Keywords: anticancer; highly conjugated ligands; light activation; luminescence; protic ligands; ruthenium.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Ru complexes herein can utilize both PACT and PDT pathways. (a) Schematic showing the excited states typically involved in PACT and PDT. 1MLCT and 3MLCT are shown here for concise presentation, but singlet oxygen formation often occurs via 3ILCT and other excited states (e.g., 3LLCT), especially with highly conjugated organic ligands. (b) A specific example showing PACT and PDT for a Ru(II) complex; thus, the complex is a dual PDT/PACT agent (e.g., complexes 1A4A herein). (c) Complexes 5A8A used herein are solely PDT agents due to a lack of steric strain near the metal center. The co-ligands in 1A8A are defined in Figure 2.
Figure 2
Figure 2
Ruthenium complexes 18 are used in the current study. Complexes 1A4A, [(6,6′-dhbp)Ru(N,N)2]Cl2, are shown in the top left, along with their basic deprotonated forms, 1B4B, which are neutral species. Complexes 5A8A, [(4,4′-dhbp)Ru(N,N)2]Cl2, are shown in the top right, along with their basic deprotonated forms, 5B8B, which are neutral species. The N,N co-ligands used herein are shown in the bottom box.
Figure 3
Figure 3
Molecular diagrams for 7A crystallized as [(dop)2Ru(4,4′-dhbp)]Cl2(H2O)3. In both views of 7A, water solvent and chloride counter anions have been removed for clarity. In the right-hand view, hydrogen atoms are hidden for clarity. Ellipsoids are shown at 50% probability. Molecular diagrams of 3A and 6A (from prior publication [28]) are included for comparison. Grey = carbon, white = hydrogen, red = oxygen, blue = nitrogen, teal = ruthenium.
Figure 4
Figure 4
Rationalizing the trends in ΦΔ of compounds 5A8A in terms of their photoluminescence (PL) dynamics. (a) Steady-state PL spectra of 8A and 8B in deaerated acetonitrile excited at their corresponding absorption peak wavelengths (483 nm and 525 nm, respectively). (b) Comparison of the time-resolved PL dynamics of 8A and 8B excited at 404 nm. (c) Time-resolved PL dynamics of 5A8A excited at 404 nm. (d) Time-resolved PL dynamics of 5B8B excited at 404 nm.
Figure 5
Figure 5
(a) Steady-state PL spectra of 3A and 3B excited at at their corresponding absorption peak wavelengths (467 nm and 529 nm, respectively). (b) Comparison of the time-resolved PL dynamics of 3A and 3B excited at 404 nm. (c) Time-resolved PL dynamics of 1A4A excited at 404 nm. (d) Time-resolved PL dynamics of 1B4B excited at 404 nm.
Figure 6
Figure 6
Correlation between the PL lifetime and singlet-oxygen QY (ΦΔ). (a) ΦΔ of compounds 5B–8B in aerated acetonitrile as a function the fast PL dynamics lifetime of these compounds in deaerated acetonitrile. The line shows calculated ϕΔ assuming the transfer time from 3MLCT to 3O2 equals 0.240 µs (from the analysis in (b)). (b) Data in (a) plotted on the reciprocal scales to determine the “average” 3MLCT to 3O2 transfer time. (c) ΦΔ of compounds 4A8A in aerated acetonitrile as a function the fast PL dynamics lifetime of these compounds in deaerated acetonitrile. The line shows calculated ΦΔ assuming the transfer time from 3MLCT to 3O2 equals 0.884 µs. (d) ΦΔ of compounds 1B3B in aerated methanol (CD3OD) as a function the fast PL dynamics lifetime of these compounds in deaerated acetonitrile.

References

    1. Fiedler E.C., Hemann M.T. Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy. Annu. Rev. Cancer Biol. 2019;3:409–428. doi: 10.1146/annurev-cancerbio-030518-055524. - DOI
    1. Monro S., Colón K.L., Yin H., Roque J., Konda P., Gujar S., Thummel R.P., Lilge L., Cameron C.G., McFarland S.A. Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. Chem. Rev. 2019;119:797–828. doi: 10.1021/acs.chemrev.8b00211. - DOI - PMC - PubMed
    1. McFarland S.A., Mandel A., Dumoulin-White R., Gasser G. Metal-based photosensitizers for photodynamic therapy: The future of multimodal oncology? Curr. Opin. Chem. Biol. 2020;56:23–27. doi: 10.1016/j.cbpa.2019.10.004. - DOI - PMC - PubMed
    1. Fong J., Kasimova K., Arenas Y., Kaspler P., Lazic S., Mandel A., Lilge L. A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors. Photochem. Photobiol. Sci. 2015;14:2014–2023. doi: 10.1039/c4pp00438h. - DOI - PubMed
    1. Papish E.T., Oladipupo O. Factors that Influence Singlet Oxygen Formation vs. Ligand Substitution for Light Activated Ruthenium Anticancer Compounds. Curr. Opin. Chem. Biol. 2022;68:102143. doi: 10.1016/j.cbpa.2022.102143. - DOI - PMC - PubMed